AstraZeneca UK vaccine trial on children paused as clot link probed
London: The decision to use the Oxford-AstraZeneca corona vaccine on young children has been postponed after it was revealed that seven people had lost their lives in the UK. Oxford said in a statement on Tuesday that research was under way into the possibility of blood clots in some people after the dose of the vaccine.
The University of Oxford said in a statement that the vaccine would be used on young children. The news that people are getting blood clots after taking the dose of this vaccine has created an atmosphere of fear among many people. Therefore, the testing of children has been postponed. The company has asked the UK’s medical regulatory agency for more information on the study.
Seven people lost their lives after being vaccinated against Oxford-AstraZeneca corona in Britain four days ago. The vaccine left 30 people with blood clots, seven of whom died, according to Britain’s medical regulatory agency.
The WHO, Europe’s drug regulator and AstraZeneca itself have repeatedly said the vaccine is completely safe. There is no evidence that this vaccine can cause blood clots or brain hemorrhage. The WHO also gave AstraZeneca a clean chit, stating that no case was found to have any connection between the vaccine and blood clots. France, Spain, Italy and Germany have banned the use of the AstraZeneca vaccine. These countries say that people have complained of blood clots after being vaccinated. France, Spain, Italy and Germany have banned the use of the AstraZeneca vaccine. These countries have said that people have complained of blood clots after being vaccinated.
#AstraZeneca #vaccine #trial #children #paused #clot #link #probed